SP-MHCI-0043-2 Antigen Peptide EBV BRLF1 HLA-A*0201 (YVLDHLIVV)

High-Quality Antigen Peptide for Research Excellence

The SP-MHCI-0043-2 Antigen Peptide EBV BRLF1 HLA-A0201 (YVLDHLIVV) is meticulously crafted to support your research needs in immunology, virology, and molecular biology. This product represents a specialized peptide designed for precision and efficacy in experimental applications.

Optimized for HLA-A0201 Binding

Featuring the YVLDHLIVV sequence, this peptide specifically targets HLA-A0201, ensuring reliable binding and accurate results in your assays. It is an ideal component for studies related to Epstein-Barr Virus (EBV) and immunogenicity.

Reliable Support for Cutting-Edge Studies

Whether you’re conducting antigen-specific T cell activation studies, epitope mapping, or vaccine development research, this top-tier peptide delivers reproducible outcomes. Rely on its purity and high-quality formulation for groundbreaking advancements in life sciences.